Literature DB >> 22343650

A simple, assumption-free, and clinically interpretable approach for analysis of modified Rankin outcomes.

George Howard1, Jennifer L Waller, Jenifer H Voeks, Virginia J Howard, Edward C Jauch, Kennedy R Lees, Fenwick T Nichols, Volker W Rahlfs, David C Hess.   

Abstract

BACKGROUND AND
PURPOSE: There is debate regarding the approach for analysis of modified Rankin scale scores, the most common functional outcome scale used in acute stroke trials.
METHODS: We propose to use tests to assess treatment differences addressing the metric, "if a patient is chosen at random from each treatment group and if they have different outcomes, what is the chance the patient who received the investigational treatment will have a better outcome than will the patient receiving the standard treatment?" This approach has an associated statement of treatment efficacy easily understood by patients and clinicians, and leads to statistical testing of treatment differences by tests closely related to the Mann-Whitney U test (Wilcoxon Rank-Sum test), which can be tested precisely by permutation tests (randomization tests).
RESULTS: We show that a permutation test is as powerful as are other approaches assessing ordinal outcomes of the modified Rankin scores, and we provide data from several examples contrasting alternative approaches. DISCUSSION: Whereas many approaches to analysis of modified Rankin scores outcomes have generally similar statistical performance, this proposed approach: captures information from the ordinal scale, provides a powerful clinical interpretation understood by both patients and clinicians, has power at least equivalent to other ordinal approaches, avoids assumptions in the parameterization, and provides an interpretable parameter based on the same foundation as the calculation of the probability value.

Entities:  

Mesh:

Year:  2012        PMID: 22343650      PMCID: PMC3838314          DOI: 10.1161/STROKEAHA.111.632935

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  12 in total

Review 1.  On the analysis and interpretation of outcome measures in stroke clinical trials: lessons from the SAINT I study of NXY-059 for acute ischemic stroke.

Authors:  James A Koziol; Anne C Feng
Journal:  Stroke       Date:  2006-08-31       Impact factor: 7.914

2.  Clinically useful measures of effect in binary analyses of randomized trials.

Authors:  J C Sinclair; M B Bracken
Journal:  J Clin Epidemiol       Date:  1994-08       Impact factor: 6.437

3.  The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis.

Authors:  Michael D Hill; Renee H Martin; Yuko Y Palesch; Diego Tamariz; Bonnie D Waldman; Karla J Ryckborst; Claudia S Moy; William G Barsan; Myron D Ginsberg
Journal:  Stroke       Date:  2011-05-05       Impact factor: 7.914

4.  Graphic reanalysis of the two NINDS-tPA trials confirms substantial treatment benefit.

Authors:  Jeffrey L Saver; Jeffrey Gornbein; Sidney Starkman
Journal:  Stroke       Date:  2010-09-09       Impact factor: 7.914

5.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

6.  The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial.

Authors:  Heleen M den Hertog; H Bart van der Worp; H Maarten A van Gemert; Ale Algra; L Jaap Kappelle; Jan van Gijn; Peter J Koudstaal; Diederik W J Dippel
Journal:  Lancet Neurol       Date:  2009-03-16       Impact factor: 44.182

7.  Outcome analysis in clinical trial design for acute stroke: physicians' attitudes and choices.

Authors:  Sean I Savitz; Michael Benatar; Jeffrey L Saver; Marc Fisher
Journal:  Cerebrovasc Dis       Date:  2008-06-17       Impact factor: 2.762

8.  Treatment effects for which shift or binary analyses are advantageous in acute stroke trials.

Authors:  Jeffrey L Saver; Jeffrey Gornbein
Journal:  Neurology       Date:  2008-12-17       Impact factor: 9.910

9.  NXY-059 for acute ischemic stroke.

Authors:  Kennedy R Lees; Justin A Zivin; Tim Ashwood; Antonio Davalos; Stephen M Davis; Hans-Christoph Diener; James Grotta; Patrick Lyden; Ashfaq Shuaib; Hans-Göran Hårdemark; Warren W Wasiewski
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

10.  Minocycline treatment in acute stroke: an open-label, evaluator-blinded study.

Authors:  Y Lampl; M Boaz; R Gilad; M Lorberboym; R Dabby; A Rapoport; M Anca-Hershkowitz; M Sadeh
Journal:  Neurology       Date:  2007-10-02       Impact factor: 9.910

View more
  22 in total

1.  Regression analysis of ordinal stroke clinical trial outcomes: an application to the NINDS t-PA trial.

Authors:  Stacia M Desantis; Christos Lazaridis; Yuko Palesch; Viswanathan Ramakrishnan
Journal:  Int J Stroke       Date:  2013-06-27       Impact factor: 5.266

2.  Stroke Treatment Academic Industry Roundtable Recommendations for Individual Data Pooling Analyses in Stroke.

Authors:  Kennedy R Lees; Pooja Khatri
Journal:  Stroke       Date:  2016-07-12       Impact factor: 7.914

3.  Functional Neurologic Outcomes Change Over the First 6 Months After Cardiac Arrest.

Authors:  Julia T Tong; Irina Eyngorn; Michael Mlynash; Gregory W Albers; Karen G Hirsch
Journal:  Crit Care Med       Date:  2016-12       Impact factor: 7.598

Review 4.  How to Measure Recovery? Revisiting Concepts and Methods for Stroke Studies.

Authors:  Marc Hommel; Olivier Detante; Isabelle Favre; Emmanuel Touzé; Assia Jaillard
Journal:  Transl Stroke Res       Date:  2016-08-08       Impact factor: 6.829

Review 5.  Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials.

Authors:  Joseph P Broderick; Opeolu Adeoye; Jordan Elm
Journal:  Stroke       Date:  2017-06-16       Impact factor: 7.914

6.  Effect Size Estimates for the ESCAPE Trial: Proportional Odds Regression Versus Other Statistical Methods.

Authors:  Tolulope T Sajobi; Yukun Zhang; Bijoy K Menon; Mayank Goyal; Andrew M Demchuk; Joseph P Broderick; Michael D Hill
Journal:  Stroke       Date:  2015-05-28       Impact factor: 7.914

7.  Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke: The EXTEND-IA TNK Part 2 Randomized Clinical Trial.

Authors:  Bruce C V Campbell; Peter J Mitchell; Leonid Churilov; Nawaf Yassi; Timothy J Kleinig; Richard J Dowling; Bernard Yan; Steven J Bush; Vincent Thijs; Rebecca Scroop; Marion Simpson; Mark Brooks; Hamed Asadi; Teddy Y Wu; Darshan G Shah; Tissa Wijeratne; Henry Zhao; Fana Alemseged; Felix Ng; Peter Bailey; Henry Rice; Laetitia de Villiers; Helen M Dewey; Philip M C Choi; Helen Brown; Kendal Redmond; David Leggett; John N Fink; Wayne Collecutt; Thomas Kraemer; Martin Krause; Dennis Cordato; Deborah Field; Henry Ma; Bill O'Brien; Benjamin Clissold; Ferdinand Miteff; Anna Clissold; Geoffrey C Cloud; Leslie E Bolitho; Luke Bonavia; Arup Bhattacharya; Alistair Wright; Abul Mamun; Fintan O'Rourke; John Worthington; Andrew A Wong; Christopher R Levi; Christopher F Bladin; Gagan Sharma; Patricia M Desmond; Mark W Parsons; Geoffrey A Donnan; Stephen M Davis
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

8.  Time to endovascular reperfusion and degree of disability in acute stroke.

Authors:  Sunil A Sheth; Reza Jahan; Jan Gralla; Vitor M Pereira; Raul G Nogueira; Elad I Levy; Osama O Zaidat; Jeffrey L Saver
Journal:  Ann Neurol       Date:  2015-08-17       Impact factor: 10.422

Review 9.  Blood Pressure Goals in Acute Stroke-How Low Do You Go?

Authors:  Iryna Lobanova; Adnan I Qureshi
Journal:  Curr Hypertens Rep       Date:  2018-04-10       Impact factor: 5.369

10.  Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials.

Authors:  Kennedy R Lees; Jonathan Emberson; Lisa Blackwell; Erich Bluhmki; Stephen M Davis; Geoffrey A Donnan; James C Grotta; Markku Kaste; Rüdiger von Kummer; Maarten G Lansberg; Richard I Lindley; Patrick Lyden; Gordon D Murray; Peter A G Sandercock; Danilo Toni; Kazunori Toyoda; Joanna M Wardlaw; William N Whiteley; Colin Baigent; Werner Hacke; George Howard
Journal:  Stroke       Date:  2016-08-09       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.